Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using κ-carrageenan as a pelletizing agent

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 336-343

  Kilor, Vaishali A ^a   Sapkal, Nidhi P ^a   Awari, Jasmine G ^b   Shewale, Bharti D ^c  

^a Near CP Foundry   (India)

^b RTM NAGPUR UNIVERSITY   (India)

^c H R Patel Women's College of Pharmacy   (India)

Author keywords

carrageenan; Aceclofenac; Enteric coated; Pellets

Indexed keywords

ACECLOFENAC; BETA CYCLODEXTRIN; CARRAGEENAN; CROSCARMELLOSE SODIUM; EUDRAGIT; POVIDONE; STARCH GLYCOLATE SODIUM;

ARTICLE; DISSOLUTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG SOLUBILITY; ENTERIC COATED TABLET; IMMEDIATE DRUG RELEASE; INFRARED SPECTROSCOPY; PARTICLE SIZE; PELLET EXTRUSION; POROSITY; PRIORITY JOURNAL; STOMACH PH; SURFACE PROPERTY; TABLET DISINTEGRATION; TABLET FRIABILITY;

ACRYLIC RESINS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CARRAGEENAN; CHEMISTRY, PHARMACEUTICAL; DICLOFENAC; DRUG IMPLANTS; EXCIPIENTS; LACTOSE; PARTICLE SIZE; PHARMACEUTICAL PREPARATIONS; POLYMERS; POVIDONE; SOLUBILITY;

EID: 77950885945     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9389-9     Document Type: Article

References (18)

1. Parfitt K. Analgesic anti inflammatory and antipyretic. In: Reynolds JEF, editor. Martindale: The complete drug reference. 32nd ed. Taunton: Pharmaceutical Press; 1999. p. 2-12.
2. R Yamazaki S Kawai T Mastsuzaki N Kaneda S Hashimoto T Yokokura R Okamoto T Koshino Y Mizushima 1997 Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors Eur J Pharmacol 329 181 187 1:CAS:528:DyaK2sXjvVynsrY%3D 9226412
3. Franz M. Stabilized pharmaceutical compositions comprising an extended release nonsteroidal anti-inflammatory agent and immediate release prostaglandin. US Patent 7303761, December 4, 2007.
4. Desai S, Nadkarni SR, Wald RJ, Debrincat GA. Dual release compositions of a cyclooxygenase-2 inhibitor. US Patent 7220434, May 22, 2007.
5. CS Yong YK Oh KH Lee SM Park YJ Park YS Gil 2005 Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects Int J Pharm 302 78 83 10.1016/j.ijpharm.2005.06.008 1:CAS:528:DC%2BD2MXpvVWisrY%3D 16107306 (Pubitemid 41242754)
6. VY Joshi MR Sawant 2006 Study on dissolution rate enhancement of poorly water soluble drug: contributions of solubility enhancement and relatively low micelle diffusivity J Disp Sci Technol 27 8 1141 1150 10.1080/01932690600859374 1:CAS:528:DC%2BD28XhtFajs7zO (Pubitemid 44355837)
7. S Dahiya K Pathak 2006 Physicochemical characterization and dissolution enhancement of aceclofenac-hydroxypropyl beta-cyclodextrin binary systems PDA J Pharm Sci Technol 60 6 378 388 1:CAS:528:DC%2BD2sXhtVCqsb7P 17260903
8. S Muatlik AN Usha MS Reddy AK Ranjith S Pandey 2007 Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies Pak J Pharm Sci 20 3 218 226 1:CAS:528: DC%2BD2sXotVCmtLw%3D 17545107
9. S Mutalik P Anju K Manoj AN Usha 2008 Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach Int J Pharm 350 1-2 279 290 10.1016/j.ijpharm.2007.09.006 1:CAS:528: DC%2BD1cXhtlGnur0%3D 17945447
10. F Yesmin MMU Talukder MS Islam S Laila T Haque 2008 Evaluation of aceclofenac loaded agarose beads prepared by ionotropic gelation method S J Pharm Sci 1 1&2 10 17 1:CAS:528:DC%2BD1MXhsVKjs7zN
11. Margret Chandira R, Venkataeswarlu BS, Kumudhavalli MV, Bhowmik D, Jayakar B. Formulation and evaluation of the fast dissolving tablets of aceclofenac. The Pharma Review. 2008; 164-67.
12. C Mallikarjuna Setty DVK Prasad VRM Gupta B SA 2008 Development of fast dispersible aceclofenac tablets: effect of functionality of superdisintegrants Ind Pharm Sci 70 2 180 185 10.4103/0250-474X.41452 (Pubitemid 351920193)
13. Ghebre-Sellassie I. Pellets: a general overview. In: Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker; 1989. p. 1-13. Vol.37.
14. PR Nassab R Rajkó P Szabó-Révész 2006 Physicochemical characterization of meloxicam-mannitol binary systems J Pharm Biomed Anal 41 1191 1197 10.1016/j.jpba.2006.02.055 1:CAS:528: DC%2BD28XltFOkt7s%3D 16621418 (Pubitemid 44218678)
15. RE O'Connor JB Schwartz 1985 Spheronization II: drug release from drug-diluent mixtures Drug Dev Ind Pharm 11 1837 1157 10.3109/03639048509057702
16. M Thommes P Kleinebudde 2006 Use of κ-carrageenan as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization, I: influence of type and fraction of filler Eur J Pharm Biopharm 63 59 67 10.1016/j.ejpb.2005.10.002 1:CAS:528:DC%2BD28XjtFGhurk%3D 16326085
17. M Thommes P Kleinebudde 2006 Use of κ-carrageenan as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization, II: influence of drug and filler type Eur J Pharm Biopharm 63 68 75 10.1016/j.ejpb.2005.10.003 1:CAS:528:DC%2BD28XjtFGhurY%3D 16325384
18. USP. The United States Pharmacopeia 2004 (USP 27). Toronto: Webcom Limited; 2003.